Amy O'Linn, DO

• President of the Lake Erie Chapter of the Society of Hospital Medicine (2011-2014)
• Cleveland Clinic Women’s Professional Staff Association (WPSA) representative to Fairview Hospital (2012-2015)
• Site director for hospital medicine at Fairview hospital (2013-2018)
• Fairview Hospital Utilization Management committee member (2013-2018)
• Sepsis Care Pathway Committee member, Enterprise and Fairview Hospital (2014-2020)
• Executive Quality Committee Member, Fairview hospital (2015-2018)
• Section Chief, Hospital Medicine, Fairview Hospital (2016-2018)
• Clinical Assistant Professor of Medicine, Hospital Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University (2016-Present)
• Clinical Assistant Professor, Hospitalist Medicine, Ohio University Heritage College of Osteopathic Medicine (2016-Present)
• Regional Hospital Medicine Quality Improvement Officer (2018-Present).
• Physician lead for Cleveland Clinic Enterprise Readmission Reduction (2018-Present)
• Cleveland Clinic Quality Alliance, Quality Committee member (2018-Present)
• Cleveland Clinic Quality Alliance, Board of Trustee member (2019-Present)
• Cleveland Clinic Advanced Peer Coach (2019- Present)
• National Quality Forum (NQF) Committee Member for Admissions and Readmissions (2020-Present)
• Frontline hospitalist during COVID Pandemic (2020-Present)
• Emerge Stronger Peer support (2021-Present)
• National Quality Forum (NQF) Co-Chair for Admissions and Readmissions (2022- Present)

• Senior Fellow of Hospital Medicine
• Fellow of American College of Physicians

See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.

As of 2026-01-27, Dr. O'Linn has reported no financial relationship with industry that is applicable to this listing.

In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.